Organic compounds -- part of the class 532-570 series inventions 03/07

20070073061 - Cyclic amine derivatives, processes for their preparation, and pharmaceutical compositions containing them: R9 and R10 independently are hydrogen, C1-4 alkyl or C3-7 cycloalkyl; m is zero or 1; n is 1 or 2; q is an integer from 1 to 4; r is 1 or 2; or pharmaceutically acceptable salts and solvates thereof; processes for their preparation to pharmaceutical compositions containing them... Agent: Glaxosmithkline Corporate Intellectual Property, Mai B475

20070066825 - Chiral ligands and their transition metal complexes: The present invention relates to chiral phosphorus compounds and their transition metal complexes, and also to the use of these transition metal complexes, especially in asymmetric syntheses.... Agent: Lanxess Corporation Patent Department

20070066826 - Grignard processes with improved yields of diphenylchlorosilanes as products: A Grignard process for preparing phenyl-containing chlorosilane products, in particular diphenylchlorosilanes, is carried out in three embodiments. In the first embodiment, the reactants of the Grignard process are a phenyl Grignard reagent, an ether solvent, a trichlorosilane, and an aromatic hydrocarbon coupling solvent. In the second embodiment, the reactants of... Agent: Dow Corning Corporation Co1232

20070066827 - Process for the preparation of aryl fused polycyclic lactams: A process for the preparation of aryl fused polycyclic lactams which are useful intermediates in the synthesis of aryl fused azapolycyclic compounds as agents for the treatment of neurological and psychological disorders.... Agent: Pfizer Inc

20070066828 - Method for making nitrogen aromatic oligomers and polymers: Methods for synthesizing dimeric or higher polymeric reaction products of nitrogen aromatics comprise contacting a composition comprising the nitrogen aromatic with a catalyst composition. The catalyst is in particulate form and comprises a first metal substrate having a second reduced metal coated on the substrate.... Agent: General Motors Corporation Legal Staff

20070066829 - Methylene blue: Composition comprising a polymerizable compound with at least one conjugated unsaturated group and methylene blue to prevent premature polymerization of the polymerizable compound. The methylene blue is present in a concentration of 10 to 5000 ppm.... Agent: Rissman Jobse Hendricks & Oliverio, LLP

20070060753 - Process for preparing intermediates useful to prepare certain antibacterial n-formyl hydroxylamines: The present invention is directed to a process for preparing intermediates that are useful to prepare certain antibacterial N-formyl hydroxylamine compounds which are peptide deformylase inhibitors.... Agent: Novartis Corporate Intellectual Property

20070060754 - Alkoxy substituted imidazoquinolines: Imidazoquinoline compounds with an alkoxy substituent at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, methods of making, and methods of use of these compounds as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of diseases including viral, and neoplastic, are... Agent: 3m Innovative Properties Company

20070060755 - Preparation of 1h-imidazo [4,5-c] quinolin-4-amines via 1h-imidazo [4,5-c] quinolin-4-phthalimide intermediates: The invention provides 1H-imidazo (4,5-c) quinoline-4-phthalimide intermediates useful in the synthesis of 1H-imidazo (4,5-c) quinoline-4-amines, particularly Imiquimod. The invention further provides a method for making the intermediates and a method for making 1H-imidazo (4,5-c) quinoline-4-amines via the intermediates.... Agent: Kenyon & Kenyon LLP

20070060756 - Process for the preparation of desloratadine: The present invention relates to an improved process for the preparation of compound of formula (I), 8-chloro-6,11-dihydro-11-(4-piperidinylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine (Desloratadine) or its pharmaceutically acceptable salts thereof, by reacting a compound of formula (II), 4-(8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1 piperidinecarboxylic acid ethyl ester (Loratadine) with sodium hydroxide in a solvent mixture of toluene and polyethylene glycol (PEG... Agent: Oliff & Berridge, PLC

20070060757 - Synthesis of enantiomerically pure amino-substituted fused bicyclic rings: This invention describes various processes for synthesis and resolution of racemic amino-substituted fused bicyclic ring systems. One process utilizes selective hydrogenation of an amino-substituted fused bicyclic aromatic ring system. An alternative process prepares the racemic amino-substituted fused bicyclic ring system via nitrosation. In addition, the present invention describes the enzymatic... Agent: Morrison & Foerster LLP